A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest.

A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest.

Currently, prognostication for pancreatic ductal adenocarcinoma (PDAC) is based upon a coarse clinical staging system. Thus, more accurate prognostic tests are needed for PDAC patients to aid treatment decisions.Affymetrix gene expression profiling was carried out on 15 human PDAC tumors and from th...

Full description

Bibliographic Details
Main Authors:	Timothy E Newhook, Edik M Blais, James M Lindberg, Sara J Adair, Wenjun Xin, Jae K Lee, Jason A Papin, J Thomas Parsons, Todd W Bauer
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4152146?pdf=render

Similar Items

Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens.
by: Dustin M Walters, et al.
Published: (2013-01-01)

Co-Treatment with Panitumumab and Trastuzumab Augments Response to the MEK Inhibitor Trametinib in a Patient-Derived Xenograft Model of Pancreatic Cancer
by: James M. Lindberg, et al.
Published: (2014-07-01)

Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients
by: Cangang Zhang, et al.
Published: (2021-07-01)

The thirteen problems /
by: Christie, Agatha, 1891-1976, author
Published: (2000)

Thirteen Abstracts
by: Fourtyseven Authors
Published: (2003-04-01)

A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.
by: Jeran K Stratford, et al.
Published: (2010-07-01)

Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts with the MEK Inhibitor Trametinib Is Augmented by Combined Treatment with the Epidermal Growth Factor Receptor/HER2 Inhibitor Lapatinib
by: Dustin M. Walters, et al.
Published: (2013-02-01)

Thirteen : the flight that failed/
by: 423463 Cooper, Henry S. F.
Published: (1973)

Thirteen years later /
by: 530854 Kent, Jasper
Published: (c201)

Introduction to Issue Thirteen
by: Laurie Moberg
Published: (2019-04-01)

Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer
by: Junliang Chen, et al.
Published: (2023-05-01)

Gene Expression and Metabolite Profiling of Thirteen Nigerian Cassava Landraces to Elucidate Starch and Carotenoid Composition
by: Priscilla Olayide, et al.
Published: (2020-03-01)

Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer
by: Chao Wu, et al.
Published: (2020-09-01)

Editorial: The journal turns thirteen
by: Per Andersson, et al.
Published: (2023-10-01)

Bigenomic transcriptional regulation of all thirteen cytochrome c oxidase subunit genes by specificity protein 1
by: Shilpa S. Dhar, et al.
Published: (2013-01-01)

Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia
by: Min Ren, et al.
Published: (2023-08-01)

Prognostic signature construction of energy metabolism-related genes in pancreatic cancer
by: Hao Liu, et al.
Published: (2022-09-01)

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma.
by: Dung-Tsa Chen, et al.
Published: (2015-01-01)

Thirteen seconds : confrontation at Kent State/
by: 321228 Eszterhas, Joe, et al.
Published: (1970)

Thirteen ways : theoretical investigations in architecture /
by: 188078 Harbison, Robert
Published: (1997)

Energy and American society, thirteen myths /
by: Sovacool, Benjamin K., et al.
Published: (2007)

Thirteen Tactics for Teaching Poetry as Architecture
by: Marsha Bryant, et al.
Published: (2022-01-01)

Thirteen Days: A Political Reading
by: İkbal Sinemden Oylumlu
Published: (2022-12-01)

Thirteen ways of looking at HDB windows
by: Tan, Yi Xin
Published: (2018)

Thirteen-level inverter for photovoltaic applications
by: Lasanthika Dissawa, et al.
Published: (2016-03-01)

Thirteen Theses on Trump and Liberal Democracy
by: Robert Howse

A survey of new temperature-sensitive, embryonic-lethal mutations in C. elegans: 24 alleles of thirteen genes.
by: Sean M O'Rourke, et al.
Published: (2011-03-01)

Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-05-01)

Reconciling high-throughput gene essentiality data with metabolic network reconstructions.
by: Anna S Blazier, et al.
Published: (2019-04-01)

Gene signature for prognosis in comparison of pancreatic cancer patients with diabetes and non-diabetes
by: Mingjun Yang, et al.
Published: (2020-11-01)

PAC-5 Gene Expression Signature for Predicting Prognosis of Patients with Pancreatic Adenocarcinoma
by: Jieun Kim, et al.
Published: (2019-11-01)

A pyroptosis-related gene signature for prognosis and immune microenvironment of pancreatic cancer
by: Sifan Tao, et al.
Published: (2022-08-01)

Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer
by: Dengchuan Wang, et al.
Published: (2023-01-01)

An Efficient Signature Based on Necroptosis-Related Genes for Prognosis of Patients With Pancreatic Cancer
by: Heng Shi, et al.
Published: (2022-03-01)

Compact Thirteen-Level Inverter for PV Applications
by: Arumbu Venkadasamy Prathaban, et al.
Published: (2022-04-01)

The Combustive Heat of Thirteen Deciduous Wood Species
by: Bolesław Porankiewicz, et al.
Published: (2016-03-01)

Thirteen new records of ferns from Brazil
by: Thais Almeida, et al.
Published: (2015-02-01)

THE TRANSLATION OF PHRASAL VERBS IN THIRTEEN REASONS WHY
by: Ance Elsy Saragih, et al.
Published: (2020-06-01)

Thirteen years on: The long journey of optometry in Ethiopia
by: Haile W. Alemu, et al.
Published: (2020-02-01)

Pyroptosis-related gene signature: A predictor for overall survival, immunotherapy response, and chemosensitivity in patients with pancreatic adenocarcinoma
by: Jieting Zhou, et al.
Published: (2023-12-01)